27.01.2023 - DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced the grant to four new employees of restricted stock units representing the contingent . Seite 1
05.01.2023 - DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced favorable coverage policies from four commercial payers including Blue Cross Blue Shield . Seite 1
06.07.2022 - DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today its membership in the Corporate Council of the Pediatric Dermatology Research Alliance . Seite 1
DermTech (NASDAQ:DMTK – Get Rating) and MDxHealth (NASDAQ:MDXH – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, risk and earnings. Earnings and Valuation This table compares DermTech and MDxHealth’s gross revenue, […]
Analysts expect DermTech, Inc. (NASDAQ:DMTK – Get Rating) to post $4.95 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for DermTech’s earnings. The lowest sales estimate is $4.90 million and the highest is $5.00 million. DermTech posted sales of $3.12 million during the same quarter last year, […]